The Challenge of Change - Managing Excipients Control
Colorcon
07-Oct-2010 - China leads the field in 'potential future' API suppliers, positioning it to become a dominant force as these companies develop, Thomson Reuters said at CPhI 2010.
07-Oct-2010 - GlaxoSmithKline has told its workforce that 55 jobs will be axed at its manufacturing base in Currabinny, Co Cork, and 66 jobs will be lost as a result of revised shift-working plans.
05-Oct-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Oso BioPharmaceuticals, Creabilis SA and Clondalkin.
04-Oct-2010 - Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber.
04-Oct-2010 - French drugmaker Sanofi Aventis has tabled an $18.5m, $69 per share, hostile takeover bid for Genzyme after failing to secure an amicable acquisition.
30-Sep-2010 - Lupin has notified the Bombay Stock Exchange (BSE) that is has acquired a majority stake in Australian pharmaceutical company, Generic Health.
29-Sep-2010 - The US FDA and NIH are funding research into bioinformatics-modelling of nanoparticles as part of a collaborative initiative to advance regulatory science.
28-Sep-2010 - TetraLogic Pharmaceuticals receives $5m (€3.7m) investment from Pfizer Ventures, helping fund clinical development of a drug that mimics naturally forming proteins, promoting cell death.
28-Sep-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.
27-Sep-2010 - The combined global market for MS disease-modifying therapies is set to grow at annual rate of 8.1 per cent from 2010 to 2015, according to a new market research report by BCC Research.
23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
23-Sep-2010 - GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its cancer immunotherapy programme.
23-Sep-2010 - India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.
22-Sep-2010 - Abbott Laboratories says it will shed manufacturing jobs as part integration of the pharmaceutical business it bought from Solvay earlier this year.
21-Sep-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Norgine, CDRD and Prometheus Laboratories.
20-Sep-2010 - SOCMA CEO predicts reintroduction of rejected permanent R&D tax credit plan and urges Congress to act “sooner rather than later” to support US manufacturers.
20-Sep-2010 - Danish biopharma giant, Novo Nordisk is expanding its R&D Centre in China by introducing a new Diabetes Research unit and doubling its quota of employees from 100 to 200 by 2015.
17-Sep-2010 - Johnson & Johnson is in advanced talks to buy biotechnology firm Crucell to boost vaccine development and manufacturing capacity.
16-Sep-2010 - Aspen Pharmacare increased operating profit by 20 per cent to R2.6bn ($368m) in its full year results.
16-Sep-2010 - Forest Pharmaceuticals has pleaded guilty to obstruction of an FDA inspection and agreed to pay $313m (€239m) in criminal and civil penalties to resolve this and other issues.
15-Sep-2010 - The US FDA has warned Bristol-Myers Squibb (B-MS) about significant GMP violations at plant in Manati, Puerto Rico, including a failure to establish anti-contamination protocols.
14-Sep-2010 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Protalix, Pevion, NeoStem and ProStraken.
13-Sep-2010 - Genzyme has confirmed plans to sell genetic testing unit to LabCorp for $925m amid media rumours that 1,000 employees face redundancy.
09-Sep-2010 - Abbott completes $2.2bn acquisition of Piramal’s Healthcare Solutions biz and predicts Indian sales of $2.5bn by 2020.
08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.